- Home
- CMMB vs OM Comparison
CMMB vs OM Comparison
Compare CMMB & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMMB | OM |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 63.9M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CMMB | OM |
|---|---|---|
| Price | $1.54 | $3.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $25.00 | $13.33 |
| AVG Volume (30 Days) | 46.0K | ★ 174.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | ★ $119,476,000.00 |
| Revenue This Year | N/A | $9.16 |
| Revenue Next Year | N/A | $11.19 |
| P/E Ratio | $39.25 | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $0.87 | $3.00 |
| 52 Week High | $3.86 | $21.98 |
Technical Indicators
Market Signals| Indicator | CMMB | OM |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 56.32 |
| Support Level | $1.48 | $3.08 |
| Resistance Level | $1.64 | $4.97 |
| Average True Range (ATR) | 0.17 | 0.24 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 19.09 | 94.29 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.